SS
PRCT icon

Steve Schonfeld’s Procept Biorobotics PRCT Stock Holding History

Steve Schonfeld’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93M Buy
129,660
+81,847
+171% +$2.05M 0.01% 876
2026
Q1 		$1.2M Sell
47,813
-20,198
-30% -$569K 0.01% 1009
2025
Q4 		$2.14M Buy
68,011
+14,513
+27% +$481K 0.01% 853
2025
Q3 		$1.91M Buy
53,498
+29,016
+119% +$1.32M 0.01% 1060
2025
Q2 		$1.41M Buy
24,482
+18,974
+344% +$1.07M 0.01% 1161
2025
Q1 		$321K Buy
5,508
+2,208
+67% +$151K ﹤0.01% 1759
2024
Q4 		$266K Sell
3,300
-2,036
-38% -$174K ﹤0.01% 1660
2024
Q3 		$428K Sell
5,336
-664
-11% -$47.2K ﹤0.01% 1506
2024
Q2 		$367K Buy
+6,000
New +$357K ﹤0.01% 1604
2023
Q2 		– Sell
-52,024
Closed -$1.48M – 2426
2023
Q1 		$1.48M Sell
52,024
-45,787
-47% -$1.62M 0.01% 788
2022
Q4 		$4.06M Buy
97,811
+51,211
+110% +$2.2M 0.03% 547
2022
Q3 		$1.93M Buy
46,600
+35,700
+328% +$1.42M 0.02% 878
2022
Q2 		$356K Buy
+10,900
New +$397K ﹤0.01% 1556

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Steve Schonfeld's PRCT Position: Q2 2026 in Review

Steve Schonfeld increased its Procept Biorobotics (PRCT) stake by 171% in Q2 2026, buying an estimated $2.05M and bringing the position to 129,660 shares worth $2.93M. The position accounts for 0.01% of the portfolio, ranked #876.

Steve Schonfeld first reported a position in PRCT in Q2 2022 and has held it in 13 quarters since. The position peaked at $4.06M in Q4 2022. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Steve Schonfeld held 129,660 shares of Procept Biorobotics worth $2.93M as of Q2 2026.
  • Steve Schonfeld bought 81,847 Procept Biorobotics shares in Q2 2026, an estimated $2.05M.
  • Procept Biorobotics made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #876 holding.
  • Steve Schonfeld first reported a position in Procept Biorobotics in Q2 2022 and has held it in 13 quarters since.
  • Steve Schonfeld's Procept Biorobotics position peaked at $4.06M in Q4 2022.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.